The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients

Tumor Biology

Volumn 25, Issue 5-6, 2004, Pages 306-312

  Schöndorf, Thomas ^a,b,d   Eisele, Lewin ^b   Göhring, Uwe Jochen ^c   Valter, Markus M ^b   Warm, Mathias ^b   Mallmann, Peter ^b   Becker, Martina ^b   Fechteler, Roland ^b   Weisshaar, Maria Paz ^a   Hoopmann, Markus ^b  

^a UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Johanniter Krankenhaus   (Germany)

^d BONN RHEIN SIEG UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Breast cancer; CDKN1B; Chemotherapy; Node involvement; p27; Polymorphism; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P27;

ADULT; ARTICLE; BREAST CANCER; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 19944429786     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081396     Document Type: Article

References (34)

1. Sherr CJ: Cancer cell cycles. Science 1996;274:1672-1677.
2. Jacks T, Weinberg RA: The expanding role of cell cycle regulators. Science 1998;280:1035-1036.
3. Wingate H, Bedrosian I, Akli S, Keyomarsi K: The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells. Cell Cycle 2003;2:461-466.
4. Alkarain A, Slingerland J: Deregulation of p27 by oncogenic signalling and its prognostic significance in breast cancer. Breast Cancer Res 2004;6:13-21.
5. Blain SW, Scher HI, Cordon-Cardo C, Koff A: p27 as a target for cancer therapeutics. Cancer Cell 2003;3:111-115.
6. Alkarain A, Jordan R, Slingerland J: p27 deregulation in breast cancer: Prognostic significance and implications for therapy. J Mammary Gland Biol Neoplasia 2004;9:67-80.
7. Esteva FJ, Hortobagyi GN: Prognostic markers in early breast cancer. Breast Cancer Res 2004;6:109-118.
8. Hayes DF: Markers of increased risk for failure of adjuvant therapies. Breast 2003;12:543-549.
9. Isaacs C, Stearns V, Hayes DF: New prognostic factors for breast cancer recurrence. Semin Oncol 2001;28:53-67.
10. Glen H, Jones RJ: 8th international conference: Primary therapy of early breast cancer, St. Gallen, Switzerland, March 12-15 2003. Breast Cancer Res 2003;5:198-201.
11. Kramer R: 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: Update on clinical research. Breast Cancer Res 2004;6:84-87.
12. Bloom HJ, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-377.
13. Scarff RW, Torloni H: Histological typing of breast tumors. International Histological Classification of Tumors. Geneva, World Health Organization 1968, vol 2, pp 13-20.
14. Schöndorf T, Göhring UJ, Becker M, Hoopmann M, Schmidt T, Rützel S, Rein DT, Ulrich U, Fechteler R, Bersch A, Mallmann P, Valter MM: High apoptotic index correlates to p21 and p27 expression indicating a favorable outcome of primary breast cancer patients, but lacking prognostic significance in multivariate analysis. Pathobiology 2004;71:217-222.
15. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M: The cell cycle inhibitor p27 is an independent prognostic marker in small (TIa,b) invasive breast carcinomas. Cancer Res 1997;57:1259-1263.
16. Kip1 protein: Prognostic implications in primary breast cancer. Nat Med 1997;3:227-230.
17. Kip1 in node-positive breast cancer. J Surg Oncol 1999;70:230-234.
18. Kip1 expression on tissue microarrays of node negative breast cancer. J Surg Oncol 2003;83:241-247.
19. Leivonen M, Nordling S, Lundin J, von Boguslawski K, Haglund C: p27 expression correlates with short-term, but not with long-term prognosis in breast cancer. Breast Cancer Res Treat 2001;67:15-22.
20. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222-225.
21. Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol 1999;187:200-206.
22. Kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer 2000;89:236-241.
23. Kip1. Breast Cancer Res Treat 1998;52:29-41.
24. Kip1 in breast cancer and its prognostic significance. J Pathol 2003;201:451-459.
25. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeushi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR, Koeffler HP: Molecular analysis of the cyclindependent Kinase Inhibitor Gene p27/Kip1 in human malignancies. Cancer Res 1995;55:2266-2269.
26. kip1 in primary breast carcinomas. Hum Genet 1996;97:91-94.
27. Ponce-Castañeda V, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Methew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C: p27: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55:1211-1214.
28. Kibel AS, Suarez BK, Belani J, Oh J, Webster R, Brophy-Ebbers M, Guo C, Catalona WJ, Picus J, Goodfellow PJ: CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Cancer Res 2003;63:2033-2036.
29. Kip1 is instigated by Jab1. Nature 1999;398:160-165.
30. Slingerland J, Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000;183:10-17.
31. Kip1 levels in node negative breast cancer. Clin Cancer Res 2003;9:5652-5659.
32. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, Santoro M: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002;8:1136-1144.
33. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL: PKB/Akt mediates cellcycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 2002;8:1145-1152.
34. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002;8:1153-1160.